Intravenous Immunoglobulin Market Size Hit $18.67Bn, Globally, by 2028 Growing at 7.6% CAGR | Exclusive Report by The Insight Partners
August 17, 2022 10:13 ET
|
The Insight Partners
New York, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type...
Monoclonal Antibody Industry Deals & Agreements, 2015 to 2022 - Access to 1,000+ Monoclonal Antibodies Deal Records, and the Leading Deals by Value Since 2015
August 16, 2022 07:53 ET
|
Research and Markets
Dublin, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global...
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
August 10, 2022 16:00 ET
|
Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
August 05, 2022 08:00 ET
|
Hyris
LONDON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- As the pandemic crisis has entered a new phase, it is a common belief among the scientific community that COVID-19 is here to stay, maybe for a long time....
BioNTech und Genmab erweitern globale strategische Kollaboration zur Entwicklung und Vermarktung neuartiger Immuntherapiekandidaten
August 05, 2022 06:45 ET
|
BioNTech SE
Ausweitung der Kollaboration zur Entwicklung monospezifischer Antikörperkandidaten gegen bösartige solide TumoreKollaboration nutzt Genmabs firmeneigene HexaBody®-Technologieplattform, um neuartige...
BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
August 05, 2022 06:45 ET
|
BioNTech SE
Collaboration expands to include development of monospecific antibody candidates to address malignant solid tumors Expanded collaboration leverages Genmab’s proprietary HexaBody® technology platform...
Global Intravenous Immunoglobulin Market Report to 2030 - Rising Adoption of Immunoglobulin Therapies is Driving Growth
July 29, 2022 07:48 ET
|
Research and Markets
Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Intravenous Immunoglobulin Market By Product Type, By Application, By Form, By End-Use, and By Region Forecast to 2030" report has been added to...
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
July 27, 2022 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
Research Antibodies & Reagents Market Research Report 2022
July 27, 2022 04:58 ET
|
Research and Markets
Dublin, July 27, 2022 (GLOBE NEWSWIRE) -- The "Global Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western Blot, Flow...
Conjugated Antibodies in Oncology Analytical Tool 2022: Must-have Reference Tool for Any Business Developer, BI/CI Operative or Clinical Developer
July 26, 2022 04:48 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Antibodies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Conjugated Antibodies in Oncology:...